GO:0005044 scavenger receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005044 scavenger receptor activity is a molecular function defined as binding to modified low-density lipoprotein (LDL) or other polyanionic ligands and delivering them into the cell via endocytosis.
• Ligands include acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, amyloid-beta fibrils, and advanced glycation end products (AGEs).
• Scavenger receptor activity is mediated by a diverse family of receptors, including SR-A1 (MSR1), CD36, LOX-1, SR-B1, and HARE/Stabilin-2, each with distinct ligand specificities.
• The activity is regulated at transcriptional and post-transcriptional levels by cytokines such as TNF-alpha and by antioxidants like alpha-tocopherol.
• Dysregulated scavenger receptor activity contributes to atherosclerosis, neurodegeneration, and host defense against pathogens.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of scavenger receptor function in health and disease.
Description
Scavenger receptor activity (GO:0005044) is a molecular function that enables cells to recognize and internalize a broad spectrum of modified or polyanionic ligands, including oxidized and acetylated low-density lipoprotein (LDL), bacterial components, apoptotic cells, amyloid-beta fibrils, and advanced glycation end products (AGEs). This activity is central to macrophage biology, innate immunity, and lipid metabolism, and its dysregulation is implicated in atherosclerosis, neurodegeneration, and chronic inflammation. Researchers study scavenger receptor activity to understand how cells clear waste, combat pathogens, and maintain tissue homeostasis, and to develop therapeutic strategies for diseases driven by impaired or excessive receptor function. The molecular function is carried out by a structurally diverse family of receptors, including SR-A1 (MSR1), CD36, LOX-1, SR-B1, and HARE/Stabilin-2, which share the ability to bind modified LDL and other polyanionic ligands but differ in tissue distribution and signaling properties. Because of its broad ligand repertoire, scavenger receptor activity is a key node at the intersection of immunity, metabolism, and protein clearance pathways.
scavenger receptor activity At A Glance
| GO ID | GO:0005044 |
|---|---|
| GO term | scavenger receptor activity |
| Ontology | molecular_function |
| Synonym | macrophage receptor activity |
| Definition | Combining with any modified low-density lipoprotein (LDL) or other polyanionic ligand and delivering the ligand into the cell via endocytosis. Ligands include acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, amyloid-beta fibrils, and advanced glycation end products (AGEs). |
| Major function | Recognition and endocytic uptake of modified LDL, pathogens, apoptotic cells, and other polyanionic ligands |
| Representative ligands | Acetylated LDL, oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, amyloid-beta fibrils, AGEs |
| Cellular context | Primarily expressed on macrophages, dendritic cells, endothelial cells, and hepatocytes |
| Related diseases | Atherosclerosis, Alzheimer's disease, chronic inflammation, and infections |
What Is GO:0005044?
Scavenger receptor activity (GO:0005044) is defined as the molecular function of combining with any modified low-density lipoprotein (LDL) or other polyanionic ligand and delivering the ligand into the cell via endocytosis. Ligands include acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, amyloid-beta fibrils, and advanced glycation end products (AGEs). This activity is synonymous with macrophage receptor activity and is characterized by the ability to bind a wide range of negatively charged macromolecules, often leading to their internalization and subsequent degradation or presentation.
Why Is scavenger receptor activity Important in Cell Biology?
Scavenger receptor activity is critically important because it mediates the clearance of modified lipoproteins, pathogens, and apoptotic cells, thereby protecting tissues from lipid accumulation, infection, and inflammation. In macrophages, this activity is a hallmark of foam cell formation in atherosclerosis, where uncontrolled uptake of oxidized LDL leads to lipid-laden cells and plaque development. Additionally, scavenger receptors contribute to innate immune defense by recognizing bacterial surface components, and to tissue remodeling by removing apoptotic cells. Dysregulated scavenger receptor activity has been linked to neurodegeneration through the binding and internalization of amyloid-beta fibrils, and to metabolic disorders via advanced glycation end product clearance. Understanding this activity is therefore essential for developing therapies targeting cardiovascular disease, Alzheimer's disease, and infectious diseases.
• Mediates foam cell formation and atherosclerosis by uptake of oxidized and acetylated LDL.
• Contributes to innate immunity by recognizing Gram-positive and Gram-negative bacteria.
• Facilitates clearance of apoptotic cells, supporting tissue homeostasis and resolution of inflammation.
• Binds amyloid-beta fibrils, implicating scavenger receptors in Alzheimer's disease pathology.
• Internalizes advanced glycation end products (AGEs), linking to diabetic complications.
• Regulated by cytokines such as TNF-alpha, connecting inflammation to lipid metabolism.
• Modulated by antioxidants like alpha-tocopherol, suggesting dietary and pharmacological control.
• Targeted by synthetic inhibitors (e.g., sulfatides, PEGylated polylysine peptides) for therapeutic intervention.
• Serves as a model system for studying endocytic receptor structure-function relationships.
• Provides a paradigm for ligand-receptor interactions in polyanionic recognition.
What Happens During scavenger receptor activity?
Ligand Recognition and Binding
In simple terms: The receptor grabs onto modified LDL or other polyanionic molecules.
Scavenger receptors bind a wide array of polyanionic ligands, including acetylated and oxidized LDL, bacterial lipopolysaccharides, apoptotic cell membranes, amyloid-beta fibrils, and advanced glycation end products (AGEs). This binding is typically mediated by positively charged clusters in the receptor's extracellular domain that interact with negatively charged ligands. The specificity and affinity vary among receptor family members, allowing for a broad surveillance function.
Endocytic Uptake
In simple terms: The receptor-ligand complex is pulled into the cell.
Upon ligand binding, scavenger receptors cluster in clathrin-coated pits and are internalized via endocytosis. This process delivers the ligand into early endosomes, where the acidic environment promotes ligand dissociation from the receptor. The receptor is then recycled back to the cell surface, while the ligand is trafficked to lysosomes for degradation.
Intracellular Processing and Signaling
In simple terms: The internalized material is broken down, and the receptor sends signals inside the cell.
After endocytosis, ligands such as oxidized LDL are degraded in lysosomes, releasing cholesterol and other lipids that can be stored as lipid droplets, leading to foam cell formation. Additionally, scavenger receptor engagement can trigger intracellular signaling cascades, including activation of NF-kB and MAPK pathways, which modulate inflammatory responses. HARE/Stabilin-2, for example, mediates both clearance and signaling functions.
Receptor Recycling and Regulation
In simple terms: The receptor goes back to the surface to grab more ligands, and its levels are controlled.
After releasing the ligand, scavenger receptors are recycled to the plasma membrane to sustain continuous uptake. The overall activity is regulated at transcriptional and post-transcriptional levels; for instance, TNF-alpha inhibits scavenger receptor activity by decreasing mRNA stability and protein synthesis. Alpha-tocopherol down-regulates scavenger receptor activity in macrophages, providing a mechanism for antioxidant modulation.
Key Genes Involved in GO:0005044 scavenger receptor activity
The following genes encode major scavenger receptors or proteins that mediate scavenger receptor activity, each with distinct ligand specificities and tissue distributions.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MSR1 | Macrophage scavenger receptor 1 (SR-A1); binds acetylated and oxidized LDL, bacteria, and apoptotic cells | Key mediator of foam cell formation and innate immunity; target for atherosclerosis research |
| CD36 | Binds oxidized LDL, fatty acids, and apoptotic cells; involved in lipid metabolism and inflammation | Implicated in atherosclerosis, insulin resistance, and Alzheimer's disease |
| OLR1 | Lectin-like oxidized LDL receptor 1 (LOX-1); binds oxidized LDL and AGEs | Endothelial dysfunction and atherosclerosis; marker of oxidative stress |
| SCARB1 | Scavenger receptor class B member 1 (SR-B1); binds HDL and oxidized LDL | Role in reverse cholesterol transport and hepatitis C virus entry |
| STAB2 | Stabilin-2 (HARE); clearance receptor for hyaluronan, AGEs, and modified LDL | Liver sinusoidal endothelial cell function; implicated in clearance of waste molecules |
| STAB1 | Stabilin-1; multifunctional scavenger receptor | Angiogenesis and immune regulation |
| CD68 | Macrosialin; binds oxidized LDL and apoptotic cells | Macrophage activation marker; role in inflammation |
| MRC1 | Mannose receptor C-type 1; binds glycoproteins and bacteria | Innate immunity and tissue homeostasis |
| AIM | Apoptosis inhibitor of macrophages (CD5L); binds polymeric IgM | Regulation of inflammation and lipid metabolism |
| SCARA3 | Scavenger receptor class A member 3; binds oxidized LDL | Cellular stress response and oxidative defense |
| SCARA5 | Scavenger receptor class A member 5; binds ferritin and bacteria | Iron homeostasis and host defense |
| COLEC12 | Collectin subfamily member 12; binds bacteria and oxidized LDL | Endothelial scavenger function |
| CXCL16 | Chemokine (C-X-C motif) ligand 16; binds oxidized LDL | Inflammation and atherosclerosis |
| CD163 | Hemoglobin scavenger receptor; binds haptoglobin-hemoglobin complexes | Anti-inflammatory and iron recycling |
| LYVE1 | Lymphatic vessel endothelial hyaluronan receptor 1; binds hyaluronan | Lymphatic function and immune cell trafficking |
| ASGR1 | Asialoglycoprotein receptor 1; binds desialylated glycoproteins | Liver-specific clearance and drug targeting |
| ASGR2 | Asialoglycoprotein receptor 2; binds desialylated glycoproteins | Hepatocyte function and glycoprotein homeostasis |
| TLR4 | Toll-like receptor 4; cooperates with scavenger receptors for bacterial recognition | Innate immunity and inflammation |
How Is scavenger receptor activity Regulated?
Scavenger receptor activity is regulated at multiple levels. Transcriptionally, cytokines such as tumor necrosis factor-alpha (TNF-alpha) inhibit scavenger receptor activity by decreasing mRNA levels and affecting post-transcriptional stability. Antioxidants like alpha-tocopherol down-regulate scavenger receptor activity in macrophages, suggesting redox-sensitive regulatory mechanisms. Additionally, synthetic inhibitors such as sulfatide derivatives and PEGylated polylysine peptides can directly block ligand binding, providing tools for experimental control. The signaling pathways downstream of scavenger receptors, including NF-kB and MAPK, can feedback to modulate receptor expression. HARE/Stabilin-2 activity is regulated by its intracellular trafficking and ligand availability.
scavenger receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MSR1 | Atherosclerosis, innate immunity | Msr1 knockout mouse; macrophage foam cell assays |
| CD36 | Atherosclerosis, insulin resistance, Alzheimer's disease | Cd36 knockout mouse; oxidized LDL uptake assays |
| OLR1 | Endothelial dysfunction, atherosclerosis | Olr1 transgenic or knockout mouse; endothelial cell models |
| STAB2 | Liver clearance disorders, inflammation | Stab2 knockout mouse; liver sinusoidal endothelial cells |
| SCARB1 | Reverse cholesterol transport, hepatitis C entry | Scarb1 knockout mouse; hepatocyte cell lines |
Atherosclerosis and Cardiovascular Disease
Uncontrolled scavenger receptor activity on macrophages leads to excessive uptake of oxidized LDL, resulting in foam cell formation and atherosclerotic plaque development. MSR1, CD36, and LOX-1 are key receptors in this process, and their inhibition or genetic deletion reduces lesion formation in animal models. Alpha-tocopherol down-regulates scavenger receptor activity, suggesting a potential preventive strategy.
Neurodegeneration and Alzheimer's Disease
Scavenger receptors such as CD36 and MSR1 bind amyloid-beta fibrils and mediate their internalization, contributing to neuroinflammation and neuronal dysfunction. This activity is thought to play a dual role in amyloid clearance and pathology, making it a target for therapeutic modulation.
Infectious Diseases and Innate Immunity
Scavenger receptors recognize Gram-positive and Gram-negative bacteria, facilitating their clearance by macrophages. However, some pathogens exploit these receptors for entry, as seen with Scavenger Receptor C1 mediating toxicity of binary toxin from Lysinibacillus sphaericus. HARE/Stabilin-2 also participates in clearance of bacterial components.
Metabolic Disorders and AGE Clearance
Advanced glycation end products (AGEs) are ligands for scavenger receptors, and their impaired clearance contributes to diabetic complications and chronic inflammation. Receptors like LOX-1 and STAB2 mediate AGE uptake, linking scavenger activity to metabolic homeostasis.
From scavenger receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MSR1 reduce foam cell formation? | MSR1 knockout macrophage cell line or mouse model |
| How does a point mutation in CD36 affect oxidized LDL binding? | CD36 point-mutant knock-in cell line |
| Can overexpression of STAB2 enhance AGE clearance? | STAB2 overexpression in hepatic cell lines |
| What is the effect of TNF-alpha on scavenger receptor activity? | TNF-alpha treated macrophages with receptor knockdown |
| Does alpha-tocopherol modulate scavenger receptor expression? | Macrophage cell lines treated with alpha-tocopherol |
| Can synthetic inhibitors block scavenger receptor-mediated gene delivery? | PEGylated polylysine peptides in reporter assays |
How to Study the scavenger receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry with fluorescent ligands | Ligand binding and internalization | Quantifying scavenger receptor activity in macrophages |
| Confocal microscopy | Subcellular localization of receptors and ligands | Visualizing endocytic trafficking |
| qRT-PCR | mRNA expression levels | Assessing transcriptional regulation by TNF-alpha |
| Western blotting | Protein expression and modification | Measuring receptor protein levels after alpha-tocopherol treatment |
| Cryo-EM | High-resolution structure of receptor-ligand complexes | Understanding ligand recognition by AIM/CD5L |
| Surface plasmon resonance | Binding kinetics and affinity | Characterizing receptor-ligand interactions |
| CRISPR knockout screens | Genes required for scavenger receptor activity | Identifying novel regulators of lipid uptake |
| Lipid droplet staining | Foam cell formation | Assessing functional consequences of scavenger receptor activity |
Ligand Binding and Uptake Assays
Fluorescently labeled ligands such as acetylated LDL, oxidized LDL, or bacteria are used to measure scavenger receptor binding and internalization via flow cytometry or confocal microscopy. These assays can be performed in wild-type and knockout cells to assess receptor specificity.
Transcriptional and Post-transcriptional Regulation Studies
Quantitative RT-PCR and western blotting are used to measure mRNA and protein levels of scavenger receptors after treatments with cytokines (e.g., TNF-alpha) or antioxidants (e.g., alpha-tocopherol). mRNA stability assays can reveal post-transcriptional mechanisms.
Structural Biology and Biophysics
Cryo-electron microscopy and X-ray crystallography provide insights into ligand recognition by scavenger receptors, as demonstrated for AIM/CD5L binding to polymeric IgM. Surface plasmon resonance and isothermal titration calorimetry can quantify binding affinities.
CRISPR Screens and Functional Genomics
Genome-wide CRISPR knockout screens can identify genes that modulate scavenger receptor activity, using fluorescent ligand uptake as a readout. Such screens have uncovered novel regulators of lipid uptake and innate immunity.
How CRISPR Can Be Used to Study GO:0005044 scavenger receptor activity
Knockout
CRISPR knockout of scavenger receptor genes such as MSR1, CD36, or STAB2 in macrophage or hepatic cell lines abolishes ligand uptake, providing definitive evidence for their role in scavenger receptor activity. Knockout models are essential for dissecting redundant functions among family members.
Point Mutation
Introducing point mutations in ligand-binding domains of scavenger receptors (e.g., CD36) via CRISPR base editing or homology-directed repair allows precise mapping of residues critical for polyanionic ligand recognition. Such models help distinguish binding from downstream signaling.
Knock-in
Knock-in of tagged versions of scavenger receptors (e.g., GFP or HA tags) enables real-time tracking of receptor trafficking and interaction partners in live cells. This approach is valuable for studying receptor recycling and endosomal sorting.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of scavenger receptors like STAB2 or OLR1 can enhance ligand uptake and reveal gain-of-function phenotypes, such as increased foam cell formation or AGE clearance. Overexpression models are useful for screening inhibitors.
How EDITGENE Supports scavenger receptor activity Research
Researchers studying scavenger receptor activity-related genes often need to determine whether a candidate gene is causally involved in ligand uptake, signaling, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of scavenger receptor genes in relevant cellular contexts.
Contact EDITGENE today to design your custom CRISPR model for scavenger receptor activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| Stab1 Knockout MB49 Cell Line | EDJ-KQ55 | Mouse | 192187 | Details Get a Quote |
| LRP1 Knockout HEK293 Cell Line | EDJ-KQ103 | Human | 4035 | Details Get a Quote |
| CD163 Knockout HEK293 Cell Line | EDJ-KQ169 | Human | 9332 | Details Get a Quote |
| VTN Knockout HEK293 Cell Line | EDJ-KQ276 | Human | 7448 | Details Get a Quote |
| AGER Knockout HEK293 Cell Line | EDJ-KQ1094 | Human | 177 | Details Get a Quote |
| CD36 Knockout HEK293 Cell Line | EDJ-KQ1885 | Human | 948 | Details Get a Quote |
| SCARF2 Knockout HEK293 Cell Line | EDJ-KQ1974 | Human | 91179 | Details Get a Quote |
| CD6 Knockout HEK293 Cell Line | EDJ-KQ2286 | Human | 923 | Details Get a Quote |
| SCARB1 Knockout HEK293 Cell Line | EDJ-KQ2450 | Human | 949 | Details Get a Quote |
| ACKR3 Knockout HEK293 Cell Line | EDJ-KQ2468 | Human | 57007 | Details Get a Quote |
| LGALS3BP Knockout HEK293 Cell Line | EDJ-KQ2621 | Human | 3959 | Details Get a Quote |
| COLEC12 Knockout HEK293 Cell Line | EDJ-KQ2802 | Human | 81035 | Details Get a Quote |
| SCARA5 Knockout HEK293 Cell Line | EDJ-KQ3142 | Human | 286133 | Details Get a Quote |
| DMBT1 Knockout HEK293 Cell Line | EDJ-KQ3712 | Human | 1755 | Details Get a Quote |
| MEGF6 Knockout HEK293 Cell Line | EDJ-KQ4506 | Human | 1953 | Details Get a Quote |
Displaying Records 1 To 15 Of 132 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About scavenger receptor activity
What is scavenger receptor activity?
Scavenger receptor activity (GO:0005044) is a molecular function where cells bind modified LDL or other polyanionic ligands and internalize them via endocytosis.
What genes are involved in scavenger receptor activity?
Key genes include MSR1, CD36, OLR1, SCARB1, STAB2, and others encoding receptors that recognize modified LDL, bacteria, and apoptotic cells.
What ligands do scavenger receptors bind?
They bind acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, amyloid-beta fibrils, and advanced glycation end products (AGEs).
How is scavenger receptor activity regulated?
It is regulated transcriptionally and post-transcriptionally by cytokines like TNF-alpha and antioxidants like alpha-tocopherol.
What diseases are associated with scavenger receptor activity?
Atherosclerosis, Alzheimer's disease, infectious diseases, and metabolic disorders are linked to dysregulated scavenger receptor activity.
How can I study scavenger receptor activity in the lab?
Common methods include fluorescent ligand uptake assays, qRT-PCR, western blotting, and CRISPR screens.
What is the role of MSR1 in scavenger receptor activity?
MSR1 (SR-A1) is a major macrophage scavenger receptor that binds acetylated and oxidized LDL, contributing to foam cell formation.
Can CRISPR be used to study scavenger receptor genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies of scavenger receptor genes.
What is the difference between scavenger receptor activity and phagocytosis?
Scavenger receptor activity specifically refers to receptor-mediated endocytosis of soluble polyanionic ligands, while phagocytosis involves engulfment of large particles.
How does alpha-tocopherol affect scavenger receptor activity?
Alpha-tocopherol down-regulates scavenger receptor activity in macrophages, potentially through antioxidant mechanisms.
Conclusion
Scavenger receptor activity (GO:0005044) is a fundamental molecular function that enables cells to recognize and internalize a diverse array of modified and polyanionic ligands, playing critical roles in immunity, lipid metabolism, and tissue homeostasis. Its dysregulation is central to atherosclerosis, neurodegeneration, and infectious diseases, making it a prime target for therapeutic intervention. Advances in CRISPR-based genome editing and functional genomics provide powerful tools to dissect the mechanisms and regulation of scavenger receptor activity, paving the way for novel treatments.
References
- 1. Teupser D et al.. 1999. Alpha-tocopherol down-regulates scavenger receptor activity in macrophages.. Atherosclerosis 144(1):109-15 PMID: 10381284
- 2. Hsu HY et al.. 1996. Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and post-transcriptionally regulated.. J Biol Chem 271(13):7767-73 PMID: 8631819
- 3. Baumhover NJ et al.. 2015. Structure-Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene Delivery.. Mol Pharm 12(12):4321-8 PMID: 26485572
- 4. Linares-Alcántara E et al.. 2022. Scavenger Receptor A1 Signaling Pathways Affecting Macrophage Functions in Innate and Adaptive Immunity.. Immunol Invest 51(6):1725-1755 PMID: 34986758
- 5. Chen Q et al.. 2024. Cryo-EM reveals structural basis for human AIM/CD5L recognition of polymeric immunoglobulin M.. Nat Commun 15(1):9387 PMID: 39477921
- 6. Yoshiizumi K et al.. 2002. Studies on scavenger receptor inhibitors. Part 1: synthesis and structure-activity relationships of novel derivatives of sulfatides.. Bioorg Med Chem 10(8):2445-60 PMID: 12057634
- 7. Zhang Q et al.. 2024. Scavenger Receptor C1 Mediates Toxicity of Binary Toxin from Lysinibacillus sphaericus to Ag55 Cells.. Toxins (Basel) 16(8) PMID: 39195779
- 8. Harris EN et al.. 2019. Ligand Binding and Signaling of HARE/Stabilin-2.. Biomolecules 9(7) PMID: 31336723
